Schonfeld Strategic Advisors LLC Rhythm Pharmaceuticals, Inc. Transaction History

Schonfeld Strategic Advisors LLC

  • $15.2 Billion
  • Q3 2025

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$46.95 - $68.11 $978,109 - $1.42 Million
20,833 Added 36.45%
77,983 $4.93 Million
Q1 2025

May 15, 2025
SELL
$48.56 - $61.02 $123,828 - $155,601
-2,550 Reduced 4.27%
57,150 $3.03 Million
Q4 2024

Feb 14, 2025
BUY
$46.91 - $67.33 $1.37 Million - $1.96 Million
29,165 Added 95.51%
59,700 $3.34 Million
Q3 2024

Nov 14, 2024
BUY
$40.81 - $55.0 $800,447 - $1.08 Million
19,614 Added 179.6%
30,535 $1.6 Million
Q2 2024

Aug 14, 2024
BUY
$35.41 - $44.37 $386,712 - $484,564
10,921 New
10,921 $448,000
Q1 2023

May 15, 2023
SELL
$16.88 - $34.24 $1.81 Million - $3.68 Million
-107,378 Reduced 88.97%
13,311 $237,000
Q4 2022

Feb 14, 2023
BUY
$22.21 - $30.25 $1.59 Million - $2.17 Million
71,786 Added 146.79%
120,689 $3.51 Million
Q3 2022

Nov 14, 2022
BUY
$4.3 - $30.85 $210,282 - $1.51 Million
48,903 New
48,903 $1.2 Million
Q4 2018

Feb 14, 2019
SELL
$24.11 - $31.34 $1.14 Million - $1.48 Million
-47,100 Closed
0 $0
Q3 2018

Nov 14, 2018
SELL
$26.99 - $35.85 $1.32 Million - $1.75 Million
-48,900 Reduced 50.94%
47,100 $1.37 Million
Q2 2018

Aug 14, 2018
BUY
$17.02 - $35.2 $1.63 Million - $3.38 Million
96,000 New
96,000 $3 Million

Others Institutions Holding RYTM

# of Institutions
282
Shares Held
486M
Call Options Held
498K
Put Options Held
150K
View Full List

About RHYTHM PHARMACEUTICALS, INC.

RYTM Quotes by TradingView
  • Ticker RYTM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,720,000
  • Market Cap $5.54B
  • Description
  • Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...
More about RYTM
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email